Cyclosporine and FK506 differentially regulate the sarcolemmal Na+-K+ pump

Journal of Pharmacology and Experimental Therapeutics

Volumn 297, Issue 2, 2001, Pages 804-810

  Mardini, Mahidi ^a,b,c   Mihailidou, Anastasia S ^b   Wong, Angela ^d   Rasmussen, Helge H ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

^d ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CYCLOSPORIN; CYCLOSPORIN A; POTASSIUM ION; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; ENZYME INHIBITION; HEART PAPILLARY MUSCLE; HISTOPATHOLOGY; KIDNEY PARENCHYMA; MALE; NEPHROTOXICITY; NONHUMAN; POTASSIUM TRANSPORT; PRIORITY JOURNAL; RABBIT; SARCOLEMMA; SODIUM TRANSPORT; TRANSPORT KINETICS;

ANIMALS; CYCLOSPORINE; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; LIGANDS; MALE; MODELS, BIOLOGICAL; NA(+)-K(+)-EXCHANGING ATPASE; PATCH-CLAMP TECHNIQUES; RABBITS; SARCOLEMMA; TACROLIMUS;

EID: 0035028275     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Sodium pump and calcium channel modulation of Mg-deficiency cardiomyopathy
2. Heterogeneity of intracellular potassium activity and membrane potential in hypoxic guinea pig ventricle
3. + pump regulation in cardiac myocytes during hyposmolar swelling
4. Cyclosporine A enhances total cell calcium independent of Na-K-ATPase in vascular smooth muscle cells
5. +
6. Increase in intracellular sodium ion activity during stimulation in mammalian cardiac muscle
7. 2+, calcineurin, and NF-AT
8. Cyclosporin treatment alters protein phosphorylation in kidney membranes
9. Steady-state current-voltage relationship of the Na/K pump in guinea pig ventricular myocytes
10. Cyclosporine toxicity in rabbits
11. + pump function in rabbit cardiac myocytes
12. Cyclosporine A-induced calcium influx in vascular smooth muscle cells and platelets is directly mediated by protein kinase C
13. + pump by insulin in rabbit cardiac myocytes
14. + pump in rabbit cardiac myocytes
15. + pump via effects on angiotensin metabolism
16. Differential regulation of Na/K-ATPase α-subunit isoform gene expressions in cardiac myocytes by ouabain and other hypertrophic stimuli
17. Influence of cyclosporine A on contractile function, calcium handling, and energetics in isolated human and rabbit myocardium
18. Ketoconazole to reduce the need for cyclosporine after cardiac transplantation
19. +-ATPase to growth-related genes in cardiac myocytes
20. +-ATPase activity by FK506 involves calcineurin
21. 2+ transients in rat cardiac myocytes
22. Cyclosporine attenuates pressure-overload hypertrophy in mice while enhancing susceptibility to decompensation and heart failure
23. + pump activation during short-term exposure of cardiac myocytes to aldosterone
24. + pump
25. + pump function in hyperaldosteronemia
26. Changes in venous compliance by bradykinin and angiotensin II and its significance for the vascular effects of cyclosporine-A
27. Prevention of cardiac hypertrophy by calcineurin inhibition
28. + pump
29. 2+-release channel in cardiac sarcoplasmic reticulum
30. Pronounced renal vasoconstriction and systemic hypertension in renal transplant patients treated with cyclosporin A versus FK506
31. +-ATPase activity in cultured rat skeletal muscle cells
32. Cyclosporin A, and minoxidil exacerbate cardiac hypertrophy in hypertrophic cardiomyopathy via a calcium-mediated pathway
33. Cyclosporine, the renin-angiotensin-aldosterone system, and renal adverse reactions
34. Interactions of cyclosporin A with phospholipid membranes: Effects of cholesterol
35. Isozymes of the Na/K ATPase
36. +-ATPase: A tissue-specific mechanism of sodium pump regulation
37. +-ATPase activity by cyclosporin
38. Calcineurin inhibition as therapy for cardiac hypertrophy and heart failure
39. Pharmacokinetic profiles of cyclosporine in rats
40. + pump activity in mammalian cardiac myocytes